CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Champions Oncology, Inc.  (CSBR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Champions Oncology's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

CSBR Gross Margin (Jan 31 2017)
III. Quarter
(Oct 31 2016)
II. Quarter
(Jul 31 2016)
I. Quarter
(Apr 30 2016)
IV. Quarter
(Jan 31 2016)
III. Quarter
Y / Y Revenue Change 39.69 % 50.02 % 30.05 % -12.44 % 39.53 %
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 828 # 613 # 669 # 63 # 666
Seq. Revenue Change -20.01 % 21.44 % 29.36 % 11.17 % -14.1 %
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2016 Gross Margin
Champions Oncology, Inc. experienced contraction in Gross Profit by -20.01 % to $4 millions and Revenue by -20.01 %, while Gross Margin fell to 100 % a new company low.

Observing third quarter 2016 results within Biotechnology & Drugs industry 46 other companies have achieved higher Gross Margin. While Gross Margin overall ranking has deteriorated compare to previous quarter from 613 to 828.
Learn about Gross Margin
CSBR's Gross Margin third quarter 2016 Company Ranking
Within: No.
Industry # 47
Sector # 147
S&P 500 # 828

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jan 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Champions Oncology's (Jan 31 2017) Gross Profit $ 4 CSBR's Income Statement
Champions Oncology's (Jan 31 2016) Gross Profit $ 3 Quarterly CSBR's Growth
CSBR's Profits by Division See CSBR's Profits by Segment

Other Gross Margin Profitability Ratios
CSBR's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
CSBR's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for CSBR's Competitors
Gross Margin Profit Margin for Champions Oncology's Suppliers
Gross Margin Profit Margin for CSBR's Customers

You may also want to know
CSBR's Annual Growth Rates CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Gross Profit Growth
CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jan 31 2017, within Biotechnology & Drugs Industry Gross MarginJan 31 2017 MRQ Gross ProfitJan 31 2017 MRQ Revenue
Skinvisible Inc  137.22 %$ 0.035 $ 0.026 
Voyager Therapeutics, Inc.  114.23 %$ 2.698 $ 2.362 
Pdl Biopharma, Inc.  102.93 %$ 68.441 $ 66.492 
Biotime Inc  101.84 %$ 1.105 $ 1.085 
Opiant Pharmaceuticals, Inc.  100.00 %$ 13.535 $ 13.535 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.832 $ 0.832 
Cocrystal Pharma, Inc.  100.00 %$ 0.126 $ 0.126 
Enzon Pharmaceuticals, Inc.  100.00 %$ 0.853 $ 0.853 
Dimension Therapeutics, Inc.  100.00 %$ 4.132 $ 4.132 
Cytrx Corp  100.00 %$ 0.100 $ 0.100 
Cytomx Therapeutics, Inc.  100.00 %$ 6.272 $ 6.272 
Neuralstem, Inc.  100.00 %$ 0.009 $ 0.009 
Oncobiologics, Inc.  100.00 %$ 0.303 $ 0.303 
Curis Inc  100.00 %$ 2.362 $ 2.362 
Champions Oncology, Inc.  100.00 %$ 3.565 $ 3.565 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Juno Therapeutics, Inc.  100.00 %$ 21.153 $ 21.153 
Myokardia Inc  100.00 %$ 28.550 $ 28.550 
Kite Pharma, Inc.  100.00 %$ 4.907 $ 4.907 
Mymetics Corp  100.00 %$ 0.346 $ 0.346 
La Jolla Pharmaceutical Co  100.00 %$ 0.085 $ 0.085 
Northsight Capital, Inc.  100.00 %$ 0.004 $ 0.004 
Idera Pharmaceuticals, Inc.  100.00 %$ 15.281 $ 15.281 
Green Meadow Products, Inc.  100.00 %$ 0.005 $ 0.005 
Spark Therapeutics, Inc.  100.00 %$ 16.303 $ 16.303 
Novavax Inc  100.00 %$ 5.399 $ 5.399 
Intellia Therapeutics, Inc.  100.00 %$ 5.627 $ 5.627 
Nantkwest, Inc.  100.00 %$ 0.014 $ 0.014 
Pulse Biosciences, Inc.  100.00 %$ 0.034 $ 0.034 
Proteostasis Therapeutics, Inc.  100.00 %$ 4.060 $ 4.060 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com